Effect of Previous Chemotherapy on the Quality of Cryopreserved Human Ovarian Tissue In Vitro

被引:31
|
作者
Azarbaijani, Babak Asadi [1 ,2 ]
Sheikhi, Mona [3 ,4 ]
Oskam, Irma C. [5 ]
Nurmio, Mirja [6 ]
Laine, Tiina [7 ,8 ]
Tinkanen, Helena [9 ]
Makinen, Sirpa [10 ]
Tanbo, Tom G. [1 ,2 ]
Hovatta, Outi [3 ]
Jahnukainen, Kirsi [7 ,8 ,11 ,12 ]
机构
[1] Oslo Univ Hosp, Women & Childrens Div, Rikshosp, Oslo, Norway
[2] Univ Oslo, Oslo, Norway
[3] Karolinska Univ Hosp, Karolinska Inst, Div Obstet & Gynecol, Stockholm, Sweden
[4] Stockholm IVF, Stockholm, Sweden
[5] Univ Oslo, Fac Vet Med & Biosci, Oslo, Norway
[6] Univ Turku, Dept Physiol & Pediat, Turku, Finland
[7] Univ Helsinki, Cent Hosp, Dept Pediat, Helsinki, Finland
[8] Univ Helsinki, Div Obstet & Gynecol, Helsinki, Finland
[9] Tampere Univ, Cent Hosp, SF-33520 Tampere, Finland
[10] Family Federat Finland, Fertil Clin, Helsinki, Finland
[11] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden
[12] Univ Hosp, Stockholm, Sweden
来源
PLOS ONE | 2015年 / 10卷 / 07期
基金
芬兰科学院; 瑞典研究理事会;
关键词
CHILDHOOD-CANCER SURVIVOR; PRIMORDIAL FOLLICLES; FERTILITY PRESERVATION; DEVELOPMENTAL COMPETENCE; PHYSIOLOGICAL FUNCTIONS; FEMALE REPRODUCTION; MOUSE OOCYTES; CYCLOPHOSPHAMIDE; CONTAMINATION; VITRIFICATION;
D O I
10.1371/journal.pone.0133985
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Cryopreservation of ovarian tissue has been widely accepted as an option for fertility preservation among cancer patients. Some patients are exposed to chemotherapy prior to ovarian tissue cryopreservation. Consequently, assessment of the developmental capacity of human ovarian tissue after chemotherapy is of primary importance. Materials In order to study the impact of previous chemotherapy on in vitro development and viability of ovarian follicles, quality control samples from 34 female cancer patients at median age of 15 years (range 1-35), cryopreserved for fertility preservation before (n = 14) or after (n = 20) initiation of chemotherapy, were thawed and cultured for 7 days. The morphology and developmental stages of ovarian follicles were studied by light microscopy before and after culture. Possible associations between follicular densities, age and exposure to alkylating agents, expressed as cyclophosphamide equivalent dose (CED) were tested. Results Exposure to chemotherapy significantly impaired the survival and development of ovarian follicles in culture. After seven days, significantly higher densities of intermediary, primary and secondary follicles and lower densities of atretic follicles was detected in the samples collected before chemotherapy. Increasing dose of alkylating agents was identified by multivariate linear regression analysis as an independent predictor of a higher density of atretic follicles, whereas increasing age of the patient predicted a better outcome with less follicle atresia and a higher density of maturing follicles. Conclusion This study provides quantitative in vitro evidence of the impact of chemotherapy on developmental capacity of cryopreserved human ovarian tissue. The results indicate that fertility preservation should be carried out, if possible, before initiation of alkylating agents in order to guarantee better in vitro survival of ovarian follicles. In addition, ovarian samples from younger girls show lower viability and fewer developing follicles in culture.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] THE EFFECT OF PREVIOUS CHEMOTHERAPY TREATMENT ON OVARIAN FOLLICLE COUNT IN OVARIAN TISSUE CRYOPRESERVED FOR FERTILITY PRESERVATION
    Robles, A. S.
    Lakhoo, K.
    Lane, S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 : A138 - A139
  • [2] Minimal residual disease of leukemia and the quality of cryopreserved human ovarian tissue in vitro
    Asadi-Azarbaijani, Babak
    Sheikhi, Mona
    Nurmio, Mirja
    Tinkanen, Helena
    Juvonen, Vesa
    Dunkel, Leo
    Hovatta, Outi
    Oskam, Irma C.
    Jahnukainen, Kirsi
    LEUKEMIA & LYMPHOMA, 2016, 57 (03) : 700 - 707
  • [3] Effective method for in-vitro culture of cryopreserved human ovarian tissue
    Isachenko, Vladimir
    Montag, Markus
    Isachenko, Evgenia
    van der Ven, Katrin
    Dorn, Christoph
    Roesing, Benjamin
    Braun, Feodor
    Sadek, Fatti
    van der Ven, Hans
    REPRODUCTIVE BIOMEDICINE ONLINE, 2006, 13 (02) : 228 - 234
  • [4] THE USE OF VEGF ON OVARIAN TISSUE IN VITRO TO ENHANCE THE VASCULARIZATION OF CRYOPRESERVED OVARIAN TISSUE
    Jackson, H.
    Getreu, N.
    O'Neill, H.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 (SUPPL 11) : S344 - S345
  • [5] Impact of first chemotherapy exposure on follicle activation and survival in human cryopreserved ovarian tissue
    Devos, Melody
    Vidal, Paula Diaz
    Bouziotis, Jason
    Anckaert, Ellen
    Dolmans, Marie-Madeleine
    Demeestere, Isabelle
    HUMAN REPRODUCTION, 2023, 38 (03) : 408 - 420
  • [6] In vitro follicular development of cryopreserved mouse ovarian tissue
    Segino, M
    Ikeda, M
    Hirahara, F
    Sato, K
    REPRODUCTION, 2005, 130 (02) : 187 - 192
  • [7] Xenografting fresh and cryopreserved human ovarian tissue
    Oktem, Ozgur
    Urman, Bulent
    FERTILITY AND STERILITY, 2009, 91 (05) : E7 - E8
  • [8] Long-term storage does not impact the quality of cryopreserved human ovarian tissue
    Raffaella Fabbri
    Maria Macciocca
    Rossella Vicenti
    Gianandrea Pasquinelli
    Giacomo Caprara
    Sabrina Valente
    Renato Seracchioli
    Roberto Paradisi
    Journal of Ovarian Research, 9
  • [9] Long-term storage does not impact the quality of cryopreserved human ovarian tissue
    Fabbri, Raffaella
    Macciocca, Maria
    Vicenti, Rossella
    Pasquinelli, Gianandrea
    Caprara, Giacomo
    Valente, Sabrina
    Seracchioli, Renato
    Paradisi, Roberto
    JOURNAL OF OVARIAN RESEARCH, 2016, 9
  • [10] Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy
    Meirow, D
    Levron, J
    Eldar-Geva, T
    Hardan, I
    Fridman, E
    Zalel, Y
    Schiff, E
    Dor, J
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (03): : 318 - 321